Investig Clin Urol.  2019 Jan;60(1):35-39. 10.4111/icu.2019.60.1.35.

Evaluation of pain and catheter-related bladder discomfort relative to balloon volumes of indwelling urinary catheters: A prospective study

• Zugail AS
• Pinar U
• Irani J

• KMID: 2434623
• DOI: http://doi.org/10.4111/icu.2019.60.1.35

Abstract

PURPOSE
To evaluate patients' tolerance to indwelling urinary catheters (IUCs) before and after reducing their balloon volumes. IUCs are a source of discomfort or pain.
MATERIALS AND METHODS
All consecutive patients hospitalized in our department with IUCs were included during the study period with some exclusion. Each patient was his/her own control before and two hours after reduction of the balloon volume (RBV) by half using two types of assessments, a visual analog scale for pain and a catheter-related bladder discomfort (CRBD) symptom questionnaire.
RESULTS
Forty-nine patients were included in our study that completed the assessments. The mean scores for pain before and after RBVs were 2.80 and 2.02, respectively. The difference was significant (p < 0.05). The mean grades of the CRBD before and after RBVs were 1.02 and 0.75, respectively. The difference was significant (p < 0.05).
CONCLUSIONS
A 50% RBV has shown a significant amelioration in tolerating the catheter.

Keyword

Clinical protocols; Pain management; Treatment outcome; Urinary bladder; Urinary catheters

MeSH Terms

Catheters
Clinical Protocols
Humans
Pain Management
Prospective Studies*
Treatment Outcome
Urinary Bladder*
Urinary Catheters*
Visual Analog Scale

Figure

• 

  Fig. 1 Box and whisker plots displaying variation in scores and grades between VAS and CRBD groups respectively, before and after deflating the balloon. VAS, visual analogic scale; CRBD, catheter-related bladder discomfort; RBV, reduction of balloon volume.

• 

  Fig. 2 A clustered column chart displaying the incidence by percentage of the severity of symptoms acquired from patients versus no symptoms before and after RBV. RBV, reduction of balloon volume; UU, urinary urgency; SD, suprapubic discomfort; PD, perineal discomfort; UD, urethral discomfort; A, agitation.

Reference

1. Diokno AC, Lapides J. Oxybutynin: a new drug with analgesic and anticholinergic properties. J Urol. 1972; 108:307–309. PMID: 5047425.

2. Yarker YE, Goa KL, Fitton A. Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability. Drugs Aging. 1995; 6:243–262. PMID: 7620236.

3. Clmett D, Jarvis B. Tolterodine: a review of its use in the treatment of overactive bladder. Drugs Aging. 2001; 18:277–304. PMID: 11341475.

4. Ergenoglu P, Akin S, Yalcin Cok O, Eker E, Kuzgunbay B, Turunc T, et al. Effect of intraoperative paracetamol on catheter-related bladder discomfort: a prospective, randomized, double-blind study. Curr Ther Res Clin Exp. 2012; 73:186–194. PMID: 24653520.

5. Agarwal A, Yadav G, Gupta D, Singh PK, Singh U. Evaluation of intra-operative tramadol for prevention of catheter-related bladder discomfort: a prospective, randomized, double-blind study. Br J Anaesth. 2008; 101:506–510. PMID: 18653496.

6. Agarwal A, Gupta D, Kumar M, Dhiraaj S, Tandon M, Singh PK. Ketamine for treatment of catheter related bladder discomfort: a prospective, randomized, placebo controlled and double blind study. Br J Anaesth. 2006; 96:587–589. PMID: 16531445.

7. Agarwal A, Dhiraaj S, Pawar S, Kapoor R, Gupta D, Singh PK. An evaluation of the efficacy of gabapentin for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double blind study. Anesth Analg. 2007; 105:1454–1457. PMID: 17959982.

8. Agarwal A, Raza M, Singhal V, Dhiraaj S, Kapoor R, Srivastava A, et al. The efficacy of tolterodine for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study. Anesth Analg. 2005; 101:1065–1067. PMID: 16192522.

9. Tauzin-Fin P, Stecken L, Sztark F. Catheter-related bladder discomfort in post-anaesthesia care unit. Ann Fr Anesth Reanim. 2012; 31:605–608. PMID: 22749555.

10. Tauzin-Fin P, Sesay M, Svartz L, Krol-Houdek MC, Maurette P. Sublingual oxybutynin reduces postoperative pain related to indwelling bladder catheter after radical retropubic prostatectomy. Br J Anaesth. 2007; 99:572–575. PMID: 17681969.

11. Bai Y, Wang X, Li X, Pu C, Yuan H, Tang Y, et al. Management of catheter-related bladder discomfort in patients who underwent elective surgery. J Endourol. 2015; 29:640–649. PMID: 25335575.

12. Agarwal A, Dhiraaj S, Singhal V, Kapoor R, Tandon M. Comparison of efficacy of oxybutynin and tolterodine for prevention of catheter related bladder discomfort: a prospective, randomized, placebocontrolled, double-blind study. Br J Anaesth. 2006; 96:377–380. PMID: 16415311.

13. Caulfield MP, Birdsall NJ. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev. 1998; 50:279–290. PMID: 9647869.

14. Yamanishi T, Chapple CR, Chess-Williams R. Which muscarinic receptor is important in the bladder? World J Urol. 2001; 19:299–306. PMID: 11760777.

15. Binhas M, Motamed C, Hawajri N, Yiou R, Marty J. Predictors of catheter-related bladder discomfort in the post-anaesthesia care unit. Ann Fr Anesth Reanim. 2011; 30:122–125. PMID: 21277735.

16. Krane LS, Bhandari M, Peabody JO, Menon M. Impact of percutaneous suprapubic tube drainage on patient discomfort after radical prostatectomy. Eur Urol. 2009; 56:325–330. PMID: 19394131.

17. Tewari A, Rao S, Mandhani A. Catheter-less robotic radical prostatectomy using a custom-made synchronous anastomotic splint and vesical urinary diversion device: report of the initial series and perioperative outcomes. BJU Int. 2008; 102:1000–1004. PMID: 18710459.